- Home
- HCC vs VERA Comparison
HCC vs VERA Comparison
Compare HCC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCC
- VERA
- Stock Information
- Founded
- HCC 2015
- VERA 2016
- Country
- HCC United States
- VERA United States
- Employees
- HCC N/A
- VERA N/A
- Industry
- HCC Coal Mining
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- HCC Energy
- VERA Health Care
- Exchange
- HCC Nasdaq
- VERA Nasdaq
- Market Cap
- HCC 2.3B
- VERA 2.0B
- IPO Year
- HCC 2017
- VERA 2021
- Fundamental
- Price
- HCC $52.58
- VERA $23.82
- Analyst Decision
- HCC Strong Buy
- VERA Buy
- Analyst Count
- HCC 5
- VERA 8
- Target Price
- HCC $70.25
- VERA $64.63
- AVG Volume (30 Days)
- HCC 1.2M
- VERA 1.4M
- Earning Date
- HCC 07-31-2025
- VERA 08-07-2025
- Dividend Yield
- HCC 0.60%
- VERA N/A
- EPS Growth
- HCC N/A
- VERA N/A
- EPS
- HCC 2.01
- VERA N/A
- Revenue
- HCC $1,319,451,000.00
- VERA N/A
- Revenue This Year
- HCC N/A
- VERA N/A
- Revenue Next Year
- HCC $33.59
- VERA N/A
- P/E Ratio
- HCC $26.31
- VERA N/A
- Revenue Growth
- HCC N/A
- VERA N/A
- 52 Week Low
- HCC $38.00
- VERA $18.53
- 52 Week High
- HCC $75.15
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- HCC 65.24
- VERA 52.93
- Support Level
- HCC $47.88
- VERA $22.57
- Resistance Level
- HCC $53.07
- VERA $24.58
- Average True Range (ATR)
- HCC 2.24
- VERA 1.22
- MACD
- HCC 0.82
- VERA 0.14
- Stochastic Oscillator
- HCC 96.02
- VERA 69.80
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.